# HYRNUO

NDC: 50419-397
Generic name: SEVABERTINIB
Labeler / Manufacturer: Bayer HealthCare Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20251119

FDA application: NDA219972

## Active ingredients

- SEVABERTINIB: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50419-397"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50419-397
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7a11334-6e7a-445b-9a16-bdcd9acbe61f